Copyright
©The Author(s) 2020.
World J Clin Oncol. May 24, 2020; 11(5): 283-293
Published online May 24, 2020. doi: 10.5306/wjco.v11.i5.283
Published online May 24, 2020. doi: 10.5306/wjco.v11.i5.283
Figure 3 Overall survival of all Invasive lobular carcinomas patients by molecular subtype.
Basal: Estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) negative; HER2+: ER, PR negative and HER2 positive; Luminal A: ER or PR positive and HER2 negative; Luminal B: ER or PR positive and HER2 positive. HER2+: Human epidermal growth factor receptor 2 positive.
- Citation: Kee GJ, Tan RYC, Rehena S, Lee JJX, Zaw MWW, Lian WX, Yeong J, Tan SM, Lim SH, Tan BKT, Yap YS, Dent RA, Wong FY, Lee GE. Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience. World J Clin Oncol 2020; 11(5): 283-293
- URL: https://www.wjgnet.com/2218-4333/full/v11/i5/283.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i5.283